What Is Epitalon? Dosage, Half-Life & How to Track It

What Epitalon is and how it works

Epitalon traces back to the work of Russian researcher Vladimir Khavinson, who studied a natural pineal-gland protein and isolated a short synthetic peptide — Ala-Glu-Asp-Gly — meant to reproduce its effect. The pineal gland is the same organ that produces melatonin, and that connection shows up in Epitalon’s two most-studied effects: support for the body’s natural melatonin production and circadian rhythm, and activity at the telomerase enzyme.

Telomerase adds length back onto telomeres, the protective caps on the ends of chromosomes that shorten with each cell division and are one of the recognized markers of cellular aging. In animal studies, Epitalon has been shown to activate telomerase and extend telomere length, and some of that research has translated into measurable lifespan extension in rodent models.

The evidence in people is thinner and worth being direct about: a handful of small human studies (mostly out of the same Russian research group) report benefits for sleep, cardiovascular markers, and general physiological function in older adults, but there is no large randomized human trial, and it is not an FDA-approved drug. Treat the mechanism as genuinely interesting and the human data as early, not settled.

Typical dosing & reconstitution

Epitalon ships as a lyophilized powder and is reconstituted with bacteriostatic water before drawing up a dose. The standard setup is a 10 mg vial dissolved in 2 mL of BAC water, giving a 5 mg/mL concentration — which makes the full 5 mg daily dose a clean 100 units on a U-100 insulin syringe (1 mL).

The dosing schedule is simpler than most peptides on this list: one dose size, run daily for a fixed number of days, then stopped.

Two courses a year is the pattern most often described — a 20-day run followed by a 4–6 month break, not continuous daily use. The reconstitution calculator handles the concentration math if you mix at a different water volume.

Half-life & why it’s cycled instead of run continuously

There isn’t a well-established human half-life figure for Epitalon to point to. What is well established is that very short peptides like this one are degraded quickly by peptidases circulating in the blood, so the practical assumption is a short window — likely minutes rather than hours — much like the other short bioregulator peptides in this class.

That fast clearance is why the protocol is daily during the 20-day course: there’s no depot effect to lean on, so each day’s effect depends on that day’s dose. The 4–6 month off-period is a separate design choice reflecting how the underlying research was structured, not a known accumulation risk from continuous dosing.

What to track & considerations

Epitalon is generally reported as well tolerated over a 20-day course, with injection-site irritation being the most common complaint. Because the mechanism involves activating telomerase — the same enzyme that, when active, allows some cancer cells to keep dividing indefinitely — an active or recent cancer history is a standard reason to talk to a doctor before starting.

What’s worth tracking is unglamorous but useful: whether you actually hit all 20 days of the course, and a sleep or general-wellbeing marker you’re watching across the cycle, since the study population it’s modeled on used it partly for circadian and age-related outcomes.

Frequently asked questions